secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001493152-25-028676
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo abandons reverse split, launches self-tender for up to 300k shares at $3.50/sh to go private
--------------------------------------------------------------------------------

- Abandons reverse stock split (1-for-2,500 to 1-for-7,500) due to cost increase from holders splitting shares to get multiple fractional payments.
- Launches self-tender offer to purchase up to 300,000 shares at $3.50 per share, aggregate up to $1.05 million.
- Tender offer designed to reduce stockholder count below 300, necessary for 'go private' transaction.
- Board may revisit reverse split or alternative transaction in future if economically beneficial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315225028676/0001493152-25-028676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315225028676/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer